Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
Harvey, formerly known as HomeHero, is a Mountain View, California-based company that specializes in providing virtual consultations with functional and naturopathic doctors, along with in-home lab testing and natural therapies. The company's mission is to help optimize health and wellness for its clients through personalized care and innovative approaches to healthcare.
Since its inception, Harvey has managed to raise a total of $22.47 million in funding, demonstrating investor interest in its unique healthcare model. The company's focus on combining virtual consultations with in-home services positions it at the intersection of telemedicine and personalized healthcare, two rapidly growing sectors in the health industry.
As of now, there is no concrete information available regarding Harvey's plans for an initial public offering (IPO). The company has not made any official announcements about going public, and we have not found any credible reports or rumors suggesting an imminent IPO. Without official statements or reliable sources, it's not possible to speculate on the likelihood or timing of a potential Harvey IPO.
For potential investors interested in the healthcare technology sector, it's important to note that the decision to go public depends on various factors, including market conditions, company growth, and strategic goals. As Harvey continues to develop its services and expand its reach, investors and industry observers may want to keep an eye on the company's progress and any future announcements regarding its funding or potential public offering plans.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While Harvey's IPO prospects remain uncertain, investors eager to gain exposure to innovative AI companies don't have to wait. At Linqto, we offer members access to interests in promising pre-IPO private companies, including potential leaders in the AI and legal tech sectors. Our platform allows you to diversify your portfolio with lower minimum investments, potentially benefiting from the growth of emerging industry disruptors like Harvey before they go public.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
